- Webinar
- May 2023
- 240 Minutes
Europe
From €476EUR$495USD£408GBP
- Webinar
- June 2022
- 240 Minutes
Global
From €476EUR$495USD£408GBP
- Webinar
- May 2021
- 90 Minutes
Global
From €183EUR$190USD£157GBP
- Webinar
- March 2021
- 90 Minutes
United States
From €183EUR$190USD£157GBP
- Webinar
- March 2021
- 180 Minutes
Global
From €327EUR$340USD£280GBP
- Webinar
- June 2020
- 90 Minutes
Global
From €183EUR$190USD£157GBP
- Webinar
- March 2020
- 90 Minutes
Global
From €183EUR$190USD£157GBP
- Webinar
- March 2020
- 60 Minutes
Global
From €183EUR$190USD£157GBP
- Webinar
- October 2019
- 120 Minutes
Global
- Webinar
- September 2019
- 120 Minutes
Global
- Webinar
- August 2019
- 90 Minutes
Global
- Webinar
- March 2019
- 120 Minutes
United States
- Webinar
- March 2019
- 90 Minutes
Global
- Webinar
- March 2019
- 120 Minutes
Global
- Webinar
- November 2018
- 90 Minutes
United States
- Webinar
- September 2018
- 90 Minutes
Global
From €183EUR$190USD£157GBP
- Webinar
- August 2018
- 90 Minutes
Global
- Webinar
- August 2018
- 180 Minutes
Global
- Webinar
- July 2018
- 180 Minutes
Global
From €327EUR$340USD£280GBP
The CGMP market is a subset of the pharmaceutical manufacturing industry, focusing on the production of drugs and other pharmaceutical products in accordance with Current Good Manufacturing Practices (CGMP). CGMPs are a set of regulations and guidelines issued by the US Food and Drug Administration (FDA) to ensure that pharmaceutical products are safe and effective. CGMPs cover all aspects of the manufacturing process, from raw materials to finished products, and include requirements for quality control, personnel training, and record keeping.
The CGMP market is highly competitive, with many large and small companies offering a variety of services. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Teva Pharmaceuticals, AstraZeneca, Bayer, and Eli Lilly. Show Less Read more